GLS and cancer: Recent investigations have reported how overexpression of IDH1mut protein in glioma cell lines downregulates TCA cycle intermediates [53] in view of the Gln demand for synthetizing 2HG and have explored the inhibition of GLS as a therapeutic approach against IDH1mut cancers [54, 55].